Cardioprotective Mechanisms of Anti-Diabetic Agents - Mechanisms of Cardioprotection by SGLT2 Inhibitors and GLP-1R Agonists
Jill Crandall, MD
Albert Einstein College of Medicine
Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.
If you believe you should have access to this media, please login.
